Lonza set to manufacture coronavirus drug for Humanigen The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonza…martin09.15.2020
Roche testing for coronavirus and flu simultaneously The U.S. Food and Drug Administration has given the Basel-based life sciences company Roche authorization to use a test that…martin09.04.2020
Hengrui Medicine sets up clinical research and development in Basel The Chinese life sciences company Hengrui Medicine is establishing a Swiss subsidiary in Basel. The European hub for clinical research…martin09.02.2020
Polyphor awarded exclusive licensing agreement for China The Basel Area-based company Polyphor has signed an exclusive licensing agreement with Fosun Pharma in China. Fosun Pharma will lead…martin08.31.2020
New label guarantees that data remains in Switzerland With the new “swiss hosting” label, the Basel-based company swiss made software Gmbh is guaranteeing that data will not be…martin08.28.2020
Switzerland Innovation Park Basel Area opens site on Novartis Campus Switzerland Innovation Park Basel Area has opened a new location at the Novartis Campus. From here, the innovation park’s operator,…martin08.17.2020
Moderna driving forward production of vaccine from Basel Moderna is opening a location in Basel and is advancing the production of the coronavirus vaccine from there. The Swiss…martin08.11.2020
Yokogawa establishes innovation center in Allschwil The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus…martin07.31.2020
Basel gains new biotech in Bright Peak Versant Ventures has made a US$35 million Series A funding commitment to Bright Peak Therapeutics and has now announced the…martin07.30.2020
Basel is “probably the most productive life sciences location in the world” Two thirds of the value added attributable to the pharmaceutical industry as a whole in Switzerland is generated in the…martin07.14.2020